Vaccine Development Current Events | Vaccine Development News | 2
|
| Page
2 of
35 |
692 Results |
|
|
|
Sort By:
Page Views | Date |
Nasal vaccine may protect against meningitis
BENIGN bugs that live in the noses of many infants have inspired a much-needed vaccine against a deadly form of meningitis. Based on the bacterium Neisseria lactamica, the prototype vaccine is showing promise against group B meningococcal meningitis and septicaemia, the potentially fatal blood... view more... (2002-04-10)
UQ research heralds vaccine technology breakthrough
Respiratory syncytial virus (RSV) infection is a widespread infant illness that has been linked to asthma and can be deadly but may be curable by the development of this new vaccine technology by the Sir Albert Sakzewski Virus Research Centre and The University of Queensland's Faculty of Biological and Chemical Sciences. view more (2007-05-09)
Footrot vaccine closer than ever
Monash University scientists have started clinical trials to find a successful vaccine against footrot in sheep. view more (2008-07-02)
Majority of children vaccinated against hepatitis B not at increased risk of MS
The majority of children vaccinated against hepatitis B are not at an increased risk of developing multiple sclerosis (MS). view more (2008-09-26)
Vaccinated infants well protected against severe pneumococcal infection in Norway
Pneumococcus is a bacterium that can cause serious illnesses in some young children, e.g. meningitis, blood poisoning and pneumonia. Most of those who become ill are previously healthy without any known predisposing factors. The bacterium is present in the nose of up to 80 - 90% of healthy young children. view more (2008-07-10)
Despite vaccine, public should not get complacent about pneumococcal disease
Although the childhood pneumococcal conjugate vaccine has been a boon in reducing the incidence invasive pneumococcal disease (IPD), the public and the medical community must not get complacent, as non-vaccine strains, some resistant to antibiotics, are on the rise, say scientists at a meeting today in Boston. view more (2008-06-03)
Scientist warns over pandemic flu vaccine 6-month time lag
New research published today (Monday April 27) from the University of Leicester and University Hospitals of Leicester NHS Trust warns of a six-month time lag before effective vaccines can be manufactured in the event of a pandemic flu outbreak. view more (2009-04-28)
Meningitis: effectiveness of preventive vaccination demonstrated
Meningitis epidemics caused by the pathogen Nesseiria meningitis (or meningococcus) provoke high mortality in children and young people under 20 years of age in sub-Saharan Africa. view more (2007-06-06)
Volunteers sought for avian flu vaccine study
Vanderbilt University Medical Center is enrolling volunteers in a study to test a new vaccine that targets avian flu, the first such vaccine against the virus. view more (2005-10-31)
TB vaccine developed at McMaster University in Canada
McMaster University researchers are about to launch Canada's first tuberculosis (TB) vaccine clinical trial with a vaccine totally designed, manufactured and tested within McMaster. view more (2009-03-20)
New MUHC study adds more evidence to clear measles mumps rubella vaccine as a risk factor for autism
A new MUHC study provides conclusive evidence that the Measles Mumps Rubella (MMR) vaccine is not associated with the development of autism spectrum disorders (ASDs). view more (2006-10-18)
Parents confused about seriousness of measles, mumps and rubella
Parents who don't allow their children to have the MMR vaccine think that measles, mumps and rubella are less serious diseases than parents whose children have been vaccinated. Also, parents of children who go unvaccinated are more likely to believe there is a link between the vaccine and autism and/or bowel disorders. view more (2004-08-23)
Smallpox Outbreak: How Long Would It Take for Vaccines To Protect People? Would it Work?
In the event of a smallpox outbreak in the United States, how long would it take for a vaccine to start protecting Americans by stimulating an immune response? A new national study led by Saint Louis University School of Medicine will attempt to answer this question. view more (2007-05-01)
NIAID describes challenges, prospects for an HIV vaccine
Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine the extraordinarily... view more... (2008-08-28)
New study suggests potential for a broadly-protective HIV vaccine
New research conducted at the Uniformed Services University of the Health Sciences (USU) suggests that it may be possible to develop a vaccine that protects against the myriad strains of the HIV virus. view more (2007-05-30)
UNC, Harvard develop inhaled TB vaccine
A new tuberculosis vaccine successfully tested at the University of North Carolina at Chapel Hill is easier to administer and store and just as effective as one commonly used worldwide. view more (2008-03-17)
Cancer vaccine one step closer
Andreea Ioan-Facsinay from Leiden University Medical Center has attached proteins from tumour cells to antibodies. With these she treated immune cells from a mouse. These treated cells were used to make a vaccine, which was shown to be effective in animal experiments. If the follow-up research is successful, vaccines against cancer will become... view more... (2003-02-14)
Malaria Vaccine Initiative And Apovia Inc. Partner To Pursue Rapid Development Of Novel Malaria Vaccine
A public-private partnership announced today promises to bring a powerful new malaria vaccine into human trials this year. The partnership between a San Diego-based biotechnology company, Apovia Inc., and the Malaria Vaccine Initiative at PATH (Program for Appropriate Technology in Health) is a multi-million dollar, multi-year agreement. The... view more... (2001-01-26)
HPV vaccine does not appear to be effective for treating pre-existing HPV infection
For women with human papillomavirus (HPV) infection, use of the HPV-16/18 vaccine will not accelerate reduction of the virus and should not be used to treat the infection, according to a study in the August 15 issue of JAMA. view more (2007-08-15)
Hope For New Meningitis Vaccine
Research performed by scientists at the School of Biomedical and Molecular Sciences, University of Surrey and the Health Protection Agency (Porton Down, Salisbury) provides hope for developing a new meningitis vaccine that will protect children against all groups of meningococcus. Published in the journal, Infection and Immunity, the research... view more... (2004-01-05)
|
|
| Page
2 of
35 |
692 Results |
|
|
|
Sort By:
Page Views | Date |
|
